Company

Rhelixa, Inc.

Rhelixa, Inc., a Tokyo biotechnology company founded in 2015, offers epigenomic analysis and the RIAS cloud data platform.

About

Founded in 2015 and headquartered in Tokyo, Rhelixa, Inc. is a biotechnology company offering epigenomic analysis. CEO and CTO Ryo Nakaki founded the company. Its services include next-generation sequencing contract analysis, bioinformatics and RIAS, a cloud platform for visualizing and interpreting biological data. The company received funding from Global Brain in August 2024, which it plans to use to advance epigenome analysis and support anti-aging research.

3Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in